Cardiol Therapeutics (CRDL) Current Leases: 2021-2022

Historic Current Leases for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $37,813.

  • Cardiol Therapeutics' Current Leases fell 10.31% to $37,813 in Q3 2022 from the same period last year, while for Sep 2022 it was $37,813, marking a year-over-year decrease of 10.31%. This contributed to the annual value of $35,675 for FY2021, which is N/A change from last year.
  • As of Q3 2022, Cardiol Therapeutics' Current Leases stood at $37,813, which was down 0.00% from $37,813 recorded in Q2 2022.
  • In the past 5 years, Cardiol Therapeutics' Current Leases registered a high of $42,469 during Q2 2021, and its lowest value of $35,468 during Q4 2021.
  • Its 2-year average for Current Leases is $38,749, with a median of $37,813 in 2022.
  • Data for Cardiol Therapeutics' Current Leases shows a maximum YoY fell of 10.96% (in 2022) over the last 5 years.
  • Cardiol Therapeutics' Current Leases (Quarterly) stood at $35,468 in 2021, then declined by 10.31% to $37,813 in 2022.
  • Its Current Leases stands at $37,813 for Q3 2022, versus $37,813 for Q2 2022 and $36,771 for Q1 2022.